Περιγραφή
For nearly 50 years, Elsevier’s Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for complete, accurate drug information in a concise, quick-access format. New to the 2026 edition are many new monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings.
New to this edition
• o New drug monographs for approximately 10-20 newly approved drugs by the FDA provides readers with the most current drug information. • o Each monograph updated as necessary with new interactions, precautions, alerts, patient teaching instructions, and other need-to-know information. Current information helps nurses feel confident in the accuracy of the information and helps prevent medication dispensing errors
Key Features
• o Annual publication prevents users from referencing outdated information. • o 40-year history of impeccable accuracy reinforces the importance of safe IV drug administration. • o Monographs on more than 400 IV drugs offers an impressive breadth of coverage that goes well beyond any comparable drug reference. • o Proven, clinically-optimized page layout keeps all dosage information for each drug on either a single page or a two-page spread to prevent hand contamination by having to turn a page. • o Highlighted Black Box Warnings and relevant content make locating critical information fast and easy. • o Special circumstances in blue-screened text call attention to important circumstances that may not warrant black box warnings. • o Convenient, alphabetical format organizes all drug monographs by generic name, allowing users to find any drug in seconds. • o Dilution and dosage charts within monographs provide quick access to essential clinical information. • o Life stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients.
